IL2, interleukin 2, 3558

N. diseases: 950; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028754
Disease: Obesity
Obesity
0.040 Biomarker disease BEFREE Analysis of transcriptional differences reveals that SI-ILC2s express higher levels of IL-2 than do WAT-ILC2s and that blockade of IL-2 signaling impairs weight gain and reduces the populations of ILC2s and ILC3s in the SI, suggesting a role for the IL-2/ILC2/3 axis in the induction of obesity. 31269440 2019
CUI: C0028754
Disease: Obesity
Obesity
0.040 GeneticVariation disease BEFREE T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors. 31824482 2019
CUI: C0028754
Disease: Obesity
Obesity
0.040 Biomarker disease BEFREE Among women with obesity, T2D was associated with breast adipocyte hypertrophy and with six plasma analytes, including four chemokines (chemokine [C-C motif] ligand 2, chemokine [C-C motif] ligand 16, chemokine [C-X-C motif] ligand 1, and chemokine [C-X-C motif] ligand 16) and two growth factors (interleukin 2 and epidermal growth factor). 28840653 2017
CUI: C0028754
Disease: Obesity
Obesity
0.040 AlteredExpression disease BEFREE However, an increase in IL-2 was observed in H individuals, whereas its levels were decreased in the Ob counterpart. 28243360 2017